skip to main |
skip to sidebar
Focal adhesions are where the cell attaches to it's substrate, whether a blood vessel or the basement membrane. The focal contacts are shown in green, the connections to other cells in blue and actin in red.
A Scientific Interpretation of Stock and Clinical Trial Data that's easy to understand
Check out Whatisthatdrug.com--new posts daily on drugs advertised in current media
Focal Adhesions: How cells crawl along
Focal adhesions are where the cell attaches to it's substrate, whether a blood vessel or the basement membrane. The focal contacts are shown in green, the connections to other cells in blue and actin in red.
About Me
- Science Food Logic
- I have wet bench research experience in pharmacology, biochemistry and cell biology. Further, I have clinical research experience in ophthalmology, pathology and immunology. I am employed full time as a research scientist in the pharmaceutical industry. In my off time, I enjoy creating fine dining dishes as well as 20 minute meals that taste like fine dining. I like to teach both professionally and in the kitchen.
Blog Archive
-
▼
2006
(300)
-
▼
November
(76)
- Arpida Shares Surge On Positive Superbug Drug Trial
- Hollis-Eden Pharma Present Positive Data
- Interesting mover in after hours: ENDP
- Dynavax Shares Rise as Hepatitis B Shot Beats Glaxo's
- Commonwealth Biotech shares soar on Mimotopes buy
- Anika Therapeutics Stock blowing up: Gets conditio...
- CytRx Phase IIa Arimoclomol Data to Be Presented a...
- Biotechnology Index down as well today:
- Targeted Genetics' stock skyrockets
- Genzyme Begins Phase 2 Pivotal Study of Clolar(R) ...
- Off Topic: Stocks Expected to move on Monday
- Amylin Pharmaceuticals to Present at Piper Jaffray...
- More Biotechnology Stocks up on Friday:
- Pharmaxis stock soars on fast track approval
- Breaking News: Bayer sells Starck to Advent, Carly...
- Analyst says Sangamo BioSciences could be target
- Nasdaq , S & P end at multiyear highs, Biotechnolo...
- An Appropriate Term Of The Day 11/22/06: Turkey
- PDL BioPharma, Inc. Announces Roche To Discontinu...
- Pharmacyclics, Inc. Announces Presentation Of Pool...
- Vion Pharmaceuticals shares up 13% today
- Cardica shares soar in FDA approval of C-Port xA s...
- Biocryst Pharmaceuticals' Fodosine Gets Orphan Sta...
- Advanced Magnetics, Inc. announces results From P...
- .FDA Approves First-Time Generic:
- Duramed Pharmaceuticals, Inc. Plan B(R) OTC Now Av...
- Good Trend
- Genentech breast-cancer drug gets FDA OK
- Antigenics Data Shows Vaccine Oncophage Produces I...
- Biotech's Business Models Evolve as Industry Matures
- Drug stocks end with gain, biotechs slip
- GlaxoSmithKline Wins Priority Review For Tykerb Ca...
- Another run at a Dow record
- Roche and FDA issue warning on tamiflu: YIKES!
- DOW scores record close today
- FDA Allows Resumption Of Immunomedics, Inc. Lupus...
- Acorda Therapeutics Added to NASDAQ Biotechnology ...
- Early Asian Update: Taiwan leads advance; Japan's ...
- Anadys Pharmaceuticals Stock jumps
- Biotechnology Stocks Finish up $4.4% today...
- Allo Therapeutics stock Up on Tuesday Afternoon
- Asian Stocks Up
- Biotechnology and Drug Stocks Mixed Today
- Illumina to buy Solexa for about $600M
- Pancreatic Islet Picture
- Novartis International AG Diabetes drug Delayed--S...
- Barr Pharmaceuticals Receives Approval for generic...
- Geron Corporation Presents Early Clinical Trial Da...
- AVANIR Pharmaceuticals (AVNR) Cuts 16% Jobs, Halts...
- EntreMed Up on Preclinical Cancer Data
- New stem cell trial for heart attack patients
- Biotechnology Stocks Rally Tuesday Afternoon
- Positive data from Antisoma's AS1404 lung cancer t...
- Colorectal Cancer, NSCLC, Breast and Ovarian Cance...
- Targeted Genetics shares jump on debt deal with Bi...
- Lots of approvals today: Will get the info posted ...
- ANA975 in a New 13-Week Pre-Clinical Toxicology St...
- Accentia Biopharmaceuticals (ABPI) Commences Fast-...
- CombinatoRx Arthritis Drug Shows Results
- Exelixis, Inc. Announces November 9 Webcast Of Cl...
- U.S. stocks set for choppy week
- AVANIR Pharmaceuticals (AVNR) Announces $15 Millio...
- Biotechnology Sector finishes down Friday, 3 points
- NovaDel Pharma (NVD) Receives FDA Approval Of Nitr...
- Viacell up on new analyst ratings
- InterMune, Inc. Teams With Roche Milestone Paymen...
- Australian Market on fire at this hour!
- Wall Street Extends Its Decline After Flat Product...
- Exelixis, Inc. Suspends Enrollment Of New Patients...
- WebMD Health to Buy Subimo for $60M
- Xoma inks deal potentially worth $100M
- MannKind Reports Larger 3rd-Quarter Loss on Increa...
- Celgene to Issue Up to 20 Million Shares As Stock ...
- Coffee suggested to lower risk of T2 Diabetes
- Pfizer Inc. (PFE) Shares Slip On Data
- Novacea Initiates Phase 1/2 Trial of AQ4N in Gliob...
-
▼
November
(76)
No comments:
Post a Comment